VIRGINIA PITTMAN: Open Payments
NPI 1962262014 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,897 in 68 payments from 36 companies in 2025. Trend: 2023 $0 · 2024 $869 · 2025 $1,897
Food & beverage: $1,817Education: $80
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $278 |
| Novartis Pharmaceuticals Corporation | 9 | $250 |
| JAZZ PHARMACEUTICALS INC. | 1 | $117 |
| Merck Sharp & Dohme LLC | 4 | $112 |
| Astellas Pharma US Inc | 2 | $108 |
| Janssen Biotech, Inc. | 4 | $86 |
| Exelixis Inc. | 3 | $80 |
| Regeneron Healthcare Solutions, Inc. | 2 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $69 |
| PUMA BIOTECHNOLOGY, INC. | 3 | $59 |
Products named: IMFINZI, ZIIHERA, KISQALI, SCEMBLIX, CABOMETYX, REBLOZYL, LIBTAYO, Nubeqa.
Industry payments across TN — which companies pay providers there.
